Schering-Plough and Bayer Ink Deal
245551
Schering-Plough (SGP:NYSE - news - research) Monday announced a broad marketing agreement with Germany&#39;s Bayer (BAY:NYSE - news - research) that both companies said will lead to a more efficient use of their marketing and sales strengths.
737950
Bayer BAYG.DE had completed its  acquisition of Roche Holding's ROG.VX consumer drugs unit,  the German chemical and drugs group said on Saturday.
220351
Shares of ViroPharma (VPHM:Nasdaq - news - research) were among the best-performing health and pharmaceutical stocks Monday after Schering-Plough (SGP:NYSE - news - research) said it would pay $10 million to license ViroPharma&#39;s cold drug.
643039
Drug giant Schering-Plough Corp. said Monday that it will pay $10 million to exercise its option to license ViroPharma Inc.&#39;s cold treatment in the United States and Canada.
35087
German drugs and chemicals group Bayer  said it planned to sell unit H.C. Starck to a consortium formed by Advent International and the Carlyle Group for 700 million euros ($908 million) plus debt.
607189
The Bayer Corporation, a subsidiary of the Bayer Group of Germany, has agreed to plead guilty and pay a $33 million criminal fine for taking part in a conspiracy
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
207911
Schering-Plough Corp.  on Monday said quarterly earnings more than doubled on growing demand for its Zetia and Vytorin cholesterol drugs and its treatments for arthritis and allergies, lifting shares 3.5 percent.
404937
Schering gets a haircut after missing earnings.
518270
AMSTERDAM -- Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines.
296490
The small pharmaceutical firm signs another big deal.
419077
LONDON (CBS.MW) -- Bayer AG (DE:575200) (BAY) Monday said it has agreed to sell its plasma products business to NPS BioTherapeutics, Inc.
633781
Schering-Plough said that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.
595740
Schering-Plough Corp. swung to a profit in the third quarter from a loss a year ago, even as sales decline slightly in the period.
501734
The European Commission clears German drug firm Bayer's 2.3bn euro acquisition of Swiss company Roche's over the counter medicines business.
395582
J&J and Schering revise their agreement over anti-TNF compounds.
583937
BAYER has formed an alliance for its struggling pharmaceuticals business with American drug-maker Schering-Plough. Drugs and chemicals group Bayer, which is in the midst of restructuring its business, said